{"id":"https://openalex.org/A5077361663","orcid":null,"observed_orcids":[],"display_name":"Kacey Anderson","raw_author_names":["K. Anderson","Kacey Anderson"],"full_name":"Kacey Anderson","works_count":18,"cited_by_count":174,"summary_stats":{"2yr_mean_citedness":4.4,"h_index":8,"i10_index":6},"ids":{"openalex":"https://openalex.org/A5077361663","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I170201317","ror":"https://ror.org/01an3r305","display_name":"University of Pittsburgh","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},"years":[2014,2013]},{"institution":{"id":"https://openalex.org/I4210140816","ror":"https://ror.org/056546b03","display_name":"Gilead Sciences (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]},"years":[2022,2021,2020,2019]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":12,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","count":8,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","count":5,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","count":5,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","count":4,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","value":5.26e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":2.76e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":2.67e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","value":2.49e-05,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","value":2.2e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9404487609863281},{"id":"112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","score":0.7760210037231445},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.7068026661872864},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.613777220249176},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5944061875343323}],"counts_by_year":[{"year":2013,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2014,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2019,"works_count":3,"oa_works_count":1,"cited_by_count":36},{"year":2020,"works_count":2,"oa_works_count":0,"cited_by_count":15},{"year":2021,"works_count":4,"oa_works_count":2,"cited_by_count":29},{"year":2022,"works_count":2,"oa_works_count":2,"cited_by_count":72},{"year":2024,"works_count":2,"oa_works_count":0,"cited_by_count":1},{"year":2025,"works_count":3,"oa_works_count":1,"cited_by_count":21}],"display_name_alternatives":["K. Anderson","Kacey Anderson"],"block_key":"k anderson","works_api_url":"https://api.openalex.org/works?filter=author.id:A5077361663","updated_date":"2026-10-10T12:59:14","created_date":"2016-06-24T00:00:00"}